找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Screening and Risk Reduction Strategies for Breast Cancer; Imaging Modality and Masakazu Toi Book 2023 The Editor(s) (if applicable) and Th

[复制链接]
查看: 45659|回复: 52
发表于 2025-3-21 16:05:52 | 显示全部楼层 |阅读模式
书目名称Screening and Risk Reduction Strategies for Breast Cancer
副标题Imaging Modality and
编辑Masakazu Toi
视频video
概述Touch upon current topics in breast cancer screening.More individualized screening system for breast cancers are focused upon.Possible understand background and advances on the risk reduction of breas
图书封面Titlebook: Screening and Risk Reduction Strategies for Breast Cancer; Imaging Modality and Masakazu Toi Book 2023 The Editor(s) (if applicable) and Th
描述.This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening...A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book.  An in-depth review of these modalities
出版日期Book 2023
关键词individualized screening; tumor heterogenity; risk reduction; lifetime risk; disease characteristics
版次1
doihttps://doi.org/10.1007/978-981-19-7630-8
isbn_softcover978-981-19-7632-2
isbn_ebook978-981-19-7630-8
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

书目名称Screening and Risk Reduction Strategies for Breast Cancer影响因子(影响力)




书目名称Screening and Risk Reduction Strategies for Breast Cancer影响因子(影响力)学科排名




书目名称Screening and Risk Reduction Strategies for Breast Cancer网络公开度




书目名称Screening and Risk Reduction Strategies for Breast Cancer网络公开度学科排名




书目名称Screening and Risk Reduction Strategies for Breast Cancer被引频次




书目名称Screening and Risk Reduction Strategies for Breast Cancer被引频次学科排名




书目名称Screening and Risk Reduction Strategies for Breast Cancer年度引用




书目名称Screening and Risk Reduction Strategies for Breast Cancer年度引用学科排名




书目名称Screening and Risk Reduction Strategies for Breast Cancer读者反馈




书目名称Screening and Risk Reduction Strategies for Breast Cancer读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:26:12 | 显示全部楼层
发表于 2025-3-22 00:52:06 | 显示全部楼层
发表于 2025-3-22 04:43:13 | 显示全部楼层
Hereditary Breast Cancer and Pathogenic Germline Variants,nd treatment of HBC. A hallmark of breast cancers is their heterogeneous nature, and it is paramount to understand the biological and clinical significance of pathogenic germline variants (PGVs) in terms of risk level and the features of PGV-associated tumours. Genetic screening can potentially be e
发表于 2025-3-22 08:43:39 | 显示全部楼层
发表于 2025-3-22 14:42:38 | 显示全部楼层
发表于 2025-3-22 18:09:20 | 显示全部楼层
Risk-Reducing Surgery for Breast Cancer,ting continues to rise. Nonetheless, despite these advances in genetics, approximately 30% of familial breast cancer risk remains unaccounted for by mutations in currently known genes. Moreover, genetic changes do not necessarily have a causative association with a diseased state, and phenotypic man
发表于 2025-3-22 23:18:13 | 显示全部楼层
发表于 2025-3-23 04:03:47 | 显示全部楼层
Biomarkers in Proteomics, proteomics sector in future. With the help of proteomics, humanity can expand its biological knowledge far beyond. For example, the proteome information can hugely impact the cancer studies in the medical and bio-healthcare sector. There has been increased number of journals publishing importance o
发表于 2025-3-23 05:51:05 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-2 08:35
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表